Otsuka Holdings Co., Ltd.
4578
Clasificación en acciones
#578
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals,... Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.
Precio por acción
$78.91
Capitalización bursátil
$41.43B
Cambio (1 día)
-0.28%
Cambio (1 año)
45.76%
País
JP
Comercio Otsuka Holdings Co., Ltd. (4578)
Categoría
Healthcare
Ratio P/E de Otsuka Holdings Co., Ltd. (4578)
Ratio P/E al October 2026 TTM: 16.13
Según los últimos informes financieros y el precio de las acciones de Otsuka Holdings Co., Ltd., el P/E actual (TTM) de la empresa es 16.13. Al final de 2024, la empresa tenía un P/E de 13.57.
Historial del ratio P/E de Otsuka Holdings Co., Ltd. desde 2009 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 16.13 | 24.57% |
| 2025 | 12.95 | -4.55% |
| 2024 | 13.57 | -42.50% |
| 2023 | 23.60 | 35.30% |
| 2022 | 17.44 | -3.22% |
| 2021 | 18.02 | 11.43% |
| 2020 | 16.17 | -22.31% |
| 2019 | 20.82 | -29.46% |
| 2018 | 29.51 | 23.83% |
| 2017 | 23.83 | -20.06% |
| 2016 | 29.81 | 7.17% |
| 2015 | 27.82 | 114.73% |
| 2014 | 12.96 | -9.44% |
| 2013 | 14.31 | -3.53% |
| 2012 | 14.83 | 16.77% |
| 2011 | 12.70 | -14.81% |
| 2010 | 14.91 | -31.17% |
| 2009 | 21.66 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 43.73 | 171.07% |
US
|
|
| 39.77 | 146.52% |
US
|
|
| 80.21 | 397.23% |
US
|
|
| 121.17 | 651.09% |
US
|
|
| 25.53 | 58.24% |
CH
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.